BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 19, 2016
View Archived Issues
Inovio Pharmaceutical's DNA Zika virus vaccine induces robust immune responses in vivo
Read More
Corvidia Therapeutics raises Series A financing, licenses lead compound from AstraZeneca
Read More
Genedrive HCV test completes successful external assessment and gets ready for clinical testing
Read More
Beloranib achieves primary efficacy endpoint in phase IIb study in patients with severe obesity
Read More
Ironwood reports phase Ia data on soluble sGC stimulator IW-1701
Read More
Pliant Therapeutics launches with focus on fibrotic disorders
Read More
Diabetes drug pioglitazone as potential preventive therapy for recurring strokes
Read More
EZH2 inhibition exhibits in vitro and in vivo antitumor activity
Read More
Curegenix initiates phase I study of CGX-1321 in advanced solid tumors
Read More
Kasuma Partners patents PCSK9 inhibitors
Read More
Brilique 60 mg approved in E.U. for patients with history of heart attack
Read More
Bayer Schering Pharma describes ATR kinase inhibitors
Read More
Merck & Co. discloses FFAR1 agonists
Read More
Novartis reports protein kinase C inhibitors
Read More
Janssen Pharmaceutica develops mGlu2 receptor modulators
Read More
European Commission approves Zurampic for hyperuricemia in gout
Read More
Ipsen acquires rights for novel radiopharmaceuticals in oncology
Read More
FDA grants breakthrough therapy designation to PKC-412 for newly diagnosed FLT3-mutated AML
Read More
Fujifilm initiates phase I trial of FF-10502 for solid tumors, advances other cancer programs
Read More
CHLA and Thermo Fisher Scientific to develop NGS-based panel for pediatric cancer research
Read More
Temcell set to launch in Japan
Read More
Nuvo Research to split into Nuvo Pharmaceuticals and Crescita Therapeutics
Read More
FDA accepts for review sNDA for Teflaro in pediatric population
Read More
FDA grants fast track designation to Nivalis's N-91115 for cystic fibrosis
Read More
Lightlake Therapeutics changes its name to Opiant Pharmaceuticals
Read More
FDA approves Harvoni for additional chronic HCV indications
Read More
Rosetta Genomics' thyroid cancer test approved in the state of New York
Read More